期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

醛糖还原酶抑制剂的研究进展 被引量：2

下载PDF
导出
摘要 醛糖还原酶是多元醇代谢通路的关键酶,对糖尿病并发症的产生有重要的影响。本文从作用机制、构效关系等方面综述了醛糖还原酶抑制剂的研究进展。
作者 陈家鹏 陈家润
机构地区 广东省大日生物化学药业有限公司 沈阳药科大学制药工程学院
出处 《现代食品与药品杂志》 CAS 2007年第3期17-21,共5页 JOurnal of Modern Food and Pharmaceuticals
关键词 药物化学 构效关系 综述 醛糖还原酶抑制剂
分类号 R914 [医药卫生—药物化学]
  • 相关文献

参考文献25

  • 1廖二元 超楚生.内分泌学[M].北京：人民卫生出版社,2001.610-611.
  • 2Ashizawa N,Aotsuka T.Benzothiazole aidose rdductase inhibitors[J].Drugs of the Future,1998,23(5):521-529.
  • 3杨喆,左联,姚天爵.醛糖还原酶抑制剂和糖尿病并发症[J].国外医学（药学分册）,1999,26(4):217-222. 被引量：25
  • 4Hisashi M,Toshio M,Iwao T,et al.Medicinal flower.vi.absolute sterostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flower of chrysanthemum indicum l.:their inhibitory activities for rat lens aldose reductase[J].Chem Pharm Bull,2002,50(7):972-975.
  • 5Wilson D,Bohren K,Gabbay K,et al.An unlikely sugar substrate site in the 1.65.structure of the human aldose reductase holoenzyme implicated in diabetic complications[J].Science,1992,257(5066):81-84.
  • 6Rondeau JM,TSte FF,Podjarny A,et al.Novel NADPHbinding domain revealed by the crystal structure of aldose reductase[J].Nature,1992,30(335):469-472.
  • 7Fuente JA,Manzanaro S,Martin MJ,et al.Synthesis,activity and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product[J].J Med Chem,2003,46(24):5208-5221.
  • 8Klebe G,Kr μMer O,Sctriffer C.Strategies for the design of inhibitors of aidose reductase,an enzyme showing pronouneed induced-fit adapatations[J].Cell Mol Life Sci,2004,61(7-8):783-793.
  • 9Sarges R,Bordner J,Dominy BW,et al.Synthesis,absolute configuration,and conformarion of the aldose reductase inhibitors sorbinil[J].J Med Chem,1985,28(11):1716-1720.
  • 10兰静,胡昌勤,宋丹青.醛糖还原酶抑制剂非达司他与糖尿病神经病变[J].中国新药杂志,2003,12(5):334-337. 被引量：5

二级参考文献14

  • 1Yang Z.ARI and diabetic complications[J].国外医学：药学分册,1999,26(4):217-222.
  • 2Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin dependent diabetes [ J ]. J Clin Invest, 1992, 90 :2548 - 2554.
  • 3Luca C, Giulio R, Paola V, et al. Diabetes complication and their potential prevention and other approaches [ J ]. Med Res Rev,1999,19(1):3-23.
  • 4Kador PF. Molecular modeling studies of aldose reductase inhibitors[J]. J Med Chem, 1994,37 : 787 - 792.
  • 5Kazuya N, Masaaki A, Hiroki S, et al. Molecular modeling studies of ARI[J ]. Drug Des Discov, 1999,16 : 155 - 163.
  • 6Wilson DK. An unlikely sugar substrate site in the 1.65A structure of the human aldose reductase holoenzyme implicated in diabetic complications[ J ]. Science, 1992,257 : 81 - 84.
  • 7EI-Kabbani O. Studies on the inhibitor-binding site of porcine AR[J]. J Biol Chem, 1997,29 : 186 - 192.
  • 8Mitsuru O, Yudiharu M, Shigeru S, et al. A potent ARI, fidarestat,its absolute configuration and interaction with the AR by XRay crystallography[ J ]. J Med Chem, 2000,43 : 2479 - 2483.
  • 9Noridki K, Kuniharo M, Akira M, et al. Effect of long term treatment with a new ARI SNK-860,on peripheral neuropathy in streptozotocin-induced diabetic rats[J]. J Diab Comp, 1994,8:27 - 32.
  • 10Yamada H. The preventive effect of ARI,SNK-860,on diabetic somatic and autonomic neuropathy in streptozotocin-induced diabetic rat[ J ]. J JPN Diabetic Soc, 1993,36 : 693 - 700.

共引文献692

同被引文献11

引证文献2

二级引证文献4

现代食品与药品杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部